Funder: National Institutes of Health (NIH)
Due Dates: April 14, 2026 (Estimated)
Funding Amounts: Not yet specified; cooperative agreement mechanism; award size and total funding to be announced.
Summary: Supports multidisciplinary consortia to accelerate structure-based immunogen design and development of HIV immunogens that elicit broadly neutralizing antibody responses for HIV therapeutics and vaccines.
Key Information: Forecasted opportunity; details subject to change.